Interestingly, this large cohort demonstrated that common IBD medications such as 5-ASA, thiopurines, and TNF-α inhibitors were not associated with arrhythmia risk, implicating disease-related inflammatory processes as the predominant factors. The gene discussed is TNF; the disease is cardiac arrhythmia.